Teva Pharmaceuticals USA is recalling 12,088 cartons of Testosterone Gel 1% (2.5 grams per unit dose) because the medication was found to be superpotent during stability testing. This means the gel contains a higher level of testosterone than specified, which was discovered through out-of-specification assay results. The affected product includes 30 unit-dose packets per carton and was distributed nationwide across the United States.
Using a superpotent drug may result in consumers receiving a higher dose of testosterone than intended. This could lead to an increased risk of adverse health effects or unexpected side effects associated with excessive testosterone exposure.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund and contact the manufacturer for further instructions.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.